Answers are grounded in this paper and cite their sources.
Dose-dependent reduction of auditory function mainly in the high frequency range has been described as a common adverse side effect of cis-platinum. Here we report on a 4-year-old girl with osteosarcoma of the right distal femur who developed acute bilateral deafness 3 days after a single infusion of high-dose cis-platinum (150 mg/m2) during preoperative chemotherapy. Sudden disabling ototoxicity should be considered when administering high-dose cis-platinum to young children.
No takes yet. Share an insight, caveat, or question.
Bührer et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: